1
MMP-3 expression was determined by enzyme-linked immunosorbent assay and quantitative polymerase chain reaction.
2
Differentially regulated transcripts were validated by reverse transcription- quantitative polymerase chain reaction.
3
The amplification was further validated with real-time quantitative polymerase chain reaction.
4
LTL was measured with a quantitative polymerase chain reaction method.
5
Gpr35 messenger RNA expression in cardiovascular tissues was assessed using quantitative polymerase chain reaction.
6
The lung tissue was characterized by histological and real-time quantitative polymerase chain reaction analysis.
7
Preferential upregulation of these plasma membrane-linked genes was validated by quantitative polymerase chain reaction.
8
Copy number analysis was measured by quantitative polymerase chain reaction and fluorescence in situ hybridization.
9
Cytokine gene expression in the urinary sediment was studied by real-time quantitative polymerase chain reaction.
10
These findings were verified by quantitative polymerase chain reaction.
11
The genotype and viral load of HPV were determined by fluorescence quantitative polymerase chain reaction.
12
Reverse transcription- quantitative polymerase chain reaction was used to validate the different expression levels of selected lncRNAs.
13
Reverse transcription- quantitative polymerase chain reaction was conducted to verify the candidate miRNAs discovered by microarray analysis.
14
Autophagy and apoptosis-related gene expression were assessed by real-time quantitative polymerase chain reaction and Western blot.
15
The expression of UASR1 in tissues and cells were detected by reverse transcription- quantitative polymerase chain reaction.
16
Real-time quantitative polymerase chain reaction evaluated RHOF expression in lymphocyte subpopulations, and normal and malignant lymphoid tissue.